Toast, Inc.

**Signal Note: Eventide Initiates Toast (TOST) Position** This $88.3M position in Toast, a restaurant software/payments platform, represents an atypical move for Eventide's biotech-focused values mandate and suggests conviction in non-pharma healthcare infrastructure. The signal carries limited relevance to biotech drug development or clinical catalysts, though Toast's healthcare vertical expansion could indirectly benefit biotech workflows; without disclosed rationale, the strategic thesis remains unclear.